Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.

Immunovia

Immunovia

0,1990SEK
+0,20% (+0,0004)
Tänään 
Ylin0,2045
Alin0,1950
Vaihto
1 MSEK
0,1990SEK
+0,20% (+0,0004)
Tänään 
Ylin0,2045
Alin0,1950
Vaihto
1 MSEK

Immunovia

Immunovia

0,1990SEK
+0,20% (+0,0004)
Tänään 
Ylin0,2045
Alin0,1950
Vaihto
1 MSEK
0,1990SEK
+0,20% (+0,0004)
Tänään 
Ylin0,2045
Alin0,1950
Vaihto
1 MSEK

Immunovia

Immunovia

0,1990SEK
+0,20% (+0,0004)
Tänään 
Ylin0,2045
Alin0,1950
Vaihto
1 MSEK
0,1990SEK
+0,20% (+0,0004)
Tänään 
Ylin0,2045
Alin0,1950
Vaihto
1 MSEK
2025 Q3 -tulosraportti
51 päivää sitten42 min

Tarjoustasot

SwedenNasdaq Stockholm
Määrä
Osto
6 100
Myynti
Määrä
19 880

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
1--
3 035--
5 841--
2 000--
119--
Ylin
0,205
VWAP
0,199
Alin
0,195
VaihtoMäärä
1 4 931 647
VWAP
0,199
Ylin
0,205
Alin
0,195
VaihtoMäärä
1 4 931 647

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Ostaneet eniten

Ostaneet eniten
VälittäjäOstettuMyytyNettoSisäinen
Anonyymi5 085 6535 085 65300

Myyneet eniten

Myyneet eniten
VälittäjäOstettuMyytyNettoSisäinen
Anonyymi5 085 6535 085 65300

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2025 Q4 -tulosraportti
24.2.
Menneet tapahtumat
2025 Q3 -tulosraportti26.11.2025
2025 Q2 -tulosraportti28.8.2025
2025 Q1 -tulosraportti14.5.2025
2024 Q4 -tulosraportti25.2.2025
2024 Q3 -tulosraportti27.11.2024

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 5 t sitten · Muokattu
    ·
    5 t sitten · Muokattu
    ·
    https://forum.placera.se/inlagg/4aecd25e-329a-4f7e-bd0c-92af5adb6ea4 What is being discussed on the Placera forum now is old November 2025 news. But Carlsquare projects a 649 % increase in "net sales" (2026E). Is that realistic or a pipe dream? Carlsquare's bear-case is 26 øre; yes, we are currently below that. Bull-case 1.8 kroner, but this must be adjusted for 100x now in February, so the new Nov-2025 corrected bear-case becomes kr 26 and kr 180 (lala-land?) https://carlsquare.com/wp-content/uploads/2025/11/Research-update-Immunovia-q3-2025-final.pdf
    4 t sitten
    ·
    4 t sitten
    ·
    Very difficult to interpret their analysis and sales estimates. They probably expect about 100 tests sold in 2025, and 800 2025, based on scaling up out-of-pocket sales. Whether that is reasonable or not, I have no idea.
  • 1 päivä sitten · Muokattu
    ·
    1 päivä sitten · Muokattu
    ·
    15:13:57 is probably a unique daily event. This is probably one of the larger stock trades in a long time, today 15. January.
    8 t sitten
    ·
    8 t sitten
    ·
    What happened then?
    5 t sitten · Muokattu
    ·
    5 t sitten · Muokattu
    ·
    Approximately 2 million shares changed hands in a single trade. I thought it was such an abnormal pattern that I wanted to mention it. Because we have had weeks of little interest in the stock. It has gone sideways, but you have also observed that the stock has minimal trust. Without trust, people do not dare to make trades. So, there has probably been a combination of investors and small-scale investors who have already left the stock. They are on greener pastures for now, I would assume? You will probably have some who believe in a correction, who do not want to take any loss. They are stuck with perhaps 10 to 70 øre negative price per their shares (figures taken a bit out of thin air, but I assume this since, approximately if one has been holding since August 2025). Because then the price was close to 1 krone. We all have different GAV, but there is probably an average. Where most people are with their investment. To make it bubble a bit, one must approach something towards GAV where people regain room to maneuver. In my eyes, the stock price is so low that people rather choose to wait. You will have some who throw in the towel then. But you will still have those who still have room to maneuver, either because they have larger holdings and / or larger cash reserves. Plus this eternal short-seller thing. They profit from decline. But they also do not profit from stagnation. There is a majority of negative sentiment, which means that as soon as someone starts buying, you have those who want out, you have short sellers, you have those with more room to maneuver. There are very many factors against turning such a stagnant stock price around. Then small news sprinkles do little good. This is "my 50 øre" (how I perceive things).
  • 1 päivä sitten · Muokattu
    ·
    1 päivä sitten · Muokattu
    ·
    For another stock, or even Immunovia on better price trends, a small insignificant piece of news showing that something is happening would have made the stock price jump up. But not for Immunovia in its current standing. Even several of the news items we saw in autumn 2025 would probably have been price-driving upwards normally. Just trying to say something about how bad the confidence in the stock is. Have a nice day. Here is today's news, apparently. I found it on the Placera forum https://www.linkedin.com/posts/immunovia-ab_earlydetection-cancerawareness-biomarkers-activity-7417331828698816512-CJlp?utm_source=share&utm_medium=member_ios&rcm=ACoAAACpSGUBjjAlR2zB3dOwz9LsNy5ipwhw7A0
  • 2 päivää sitten · Muokattu
    ·
    2 päivää sitten · Muokattu
    ·
    @Micketro Hi, I see that you are replying in the Placera forum as Krosen. https://forum.placera.se/inlagg/32d5c8b1-4053-4ed5-9a85-46bc1c7ef9a9 There's nothing new under the sun, I guess. If you yourself are an owner in the stock, what's the point of strengthening pessimism? There are probably others who write pessimistically. I'm just a little disappointed that the serious ones are starting to become slightly pessimistic, if you understand. One only helps short sellers feel more secure. Just saw around 10 o'clock someone on the sell side with over a million shares for sale. https://www.fi.se/sv/vara-register/blankningsregistret/emittent?id=549300KHWL6KK1XGUO81
    2 päivää sitten · Muokattu
    ·
    2 päivää sitten · Muokattu
    ·
    As soon as someone with larger stock positions sells out, it will automatically lead to a large drop. Why people don't have the nerve and at least wait until Q2 in 2026, the financial report, which the company has enough financing to reach. That's certainly their business.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    2 million shares at this level is almost nothing in terms of money for the richer ones, even if such sums mean a bit to me. Then they are far from empty, and there is probably one or another guarantor who believes in Immunovia too, right?
  • 9.1.
    ·
    9.1.
    ·
    Following Immunovia on Linkedin and it's clear that they are really investing commercially now. They have recruited 3 Account Managers and some other commercial roles. Naturally, this also means increased costs so... hopefully, sales will slowly start to pick up.
    22 t sitten
    ·
    22 t sitten
    ·
    7 421 900 %. the stock must go up if I am to break even. I'm holding on and strongly believe in the company👍
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 Q3 -tulosraportti
51 päivää sitten42 min

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 5 t sitten · Muokattu
    ·
    5 t sitten · Muokattu
    ·
    https://forum.placera.se/inlagg/4aecd25e-329a-4f7e-bd0c-92af5adb6ea4 What is being discussed on the Placera forum now is old November 2025 news. But Carlsquare projects a 649 % increase in "net sales" (2026E). Is that realistic or a pipe dream? Carlsquare's bear-case is 26 øre; yes, we are currently below that. Bull-case 1.8 kroner, but this must be adjusted for 100x now in February, so the new Nov-2025 corrected bear-case becomes kr 26 and kr 180 (lala-land?) https://carlsquare.com/wp-content/uploads/2025/11/Research-update-Immunovia-q3-2025-final.pdf
    4 t sitten
    ·
    4 t sitten
    ·
    Very difficult to interpret their analysis and sales estimates. They probably expect about 100 tests sold in 2025, and 800 2025, based on scaling up out-of-pocket sales. Whether that is reasonable or not, I have no idea.
  • 1 päivä sitten · Muokattu
    ·
    1 päivä sitten · Muokattu
    ·
    15:13:57 is probably a unique daily event. This is probably one of the larger stock trades in a long time, today 15. January.
    8 t sitten
    ·
    8 t sitten
    ·
    What happened then?
    5 t sitten · Muokattu
    ·
    5 t sitten · Muokattu
    ·
    Approximately 2 million shares changed hands in a single trade. I thought it was such an abnormal pattern that I wanted to mention it. Because we have had weeks of little interest in the stock. It has gone sideways, but you have also observed that the stock has minimal trust. Without trust, people do not dare to make trades. So, there has probably been a combination of investors and small-scale investors who have already left the stock. They are on greener pastures for now, I would assume? You will probably have some who believe in a correction, who do not want to take any loss. They are stuck with perhaps 10 to 70 øre negative price per their shares (figures taken a bit out of thin air, but I assume this since, approximately if one has been holding since August 2025). Because then the price was close to 1 krone. We all have different GAV, but there is probably an average. Where most people are with their investment. To make it bubble a bit, one must approach something towards GAV where people regain room to maneuver. In my eyes, the stock price is so low that people rather choose to wait. You will have some who throw in the towel then. But you will still have those who still have room to maneuver, either because they have larger holdings and / or larger cash reserves. Plus this eternal short-seller thing. They profit from decline. But they also do not profit from stagnation. There is a majority of negative sentiment, which means that as soon as someone starts buying, you have those who want out, you have short sellers, you have those with more room to maneuver. There are very many factors against turning such a stagnant stock price around. Then small news sprinkles do little good. This is "my 50 øre" (how I perceive things).
  • 1 päivä sitten · Muokattu
    ·
    1 päivä sitten · Muokattu
    ·
    For another stock, or even Immunovia on better price trends, a small insignificant piece of news showing that something is happening would have made the stock price jump up. But not for Immunovia in its current standing. Even several of the news items we saw in autumn 2025 would probably have been price-driving upwards normally. Just trying to say something about how bad the confidence in the stock is. Have a nice day. Here is today's news, apparently. I found it on the Placera forum https://www.linkedin.com/posts/immunovia-ab_earlydetection-cancerawareness-biomarkers-activity-7417331828698816512-CJlp?utm_source=share&utm_medium=member_ios&rcm=ACoAAACpSGUBjjAlR2zB3dOwz9LsNy5ipwhw7A0
  • 2 päivää sitten · Muokattu
    ·
    2 päivää sitten · Muokattu
    ·
    @Micketro Hi, I see that you are replying in the Placera forum as Krosen. https://forum.placera.se/inlagg/32d5c8b1-4053-4ed5-9a85-46bc1c7ef9a9 There's nothing new under the sun, I guess. If you yourself are an owner in the stock, what's the point of strengthening pessimism? There are probably others who write pessimistically. I'm just a little disappointed that the serious ones are starting to become slightly pessimistic, if you understand. One only helps short sellers feel more secure. Just saw around 10 o'clock someone on the sell side with over a million shares for sale. https://www.fi.se/sv/vara-register/blankningsregistret/emittent?id=549300KHWL6KK1XGUO81
    2 päivää sitten · Muokattu
    ·
    2 päivää sitten · Muokattu
    ·
    As soon as someone with larger stock positions sells out, it will automatically lead to a large drop. Why people don't have the nerve and at least wait until Q2 in 2026, the financial report, which the company has enough financing to reach. That's certainly their business.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    2 million shares at this level is almost nothing in terms of money for the richer ones, even if such sums mean a bit to me. Then they are far from empty, and there is probably one or another guarantor who believes in Immunovia too, right?
  • 9.1.
    ·
    9.1.
    ·
    Following Immunovia on Linkedin and it's clear that they are really investing commercially now. They have recruited 3 Account Managers and some other commercial roles. Naturally, this also means increased costs so... hopefully, sales will slowly start to pick up.
    22 t sitten
    ·
    22 t sitten
    ·
    7 421 900 %. the stock must go up if I am to break even. I'm holding on and strongly believe in the company👍
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

SwedenNasdaq Stockholm
Määrä
Osto
6 100
Myynti
Määrä
19 880

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
1--
3 035--
5 841--
2 000--
119--
Ylin
0,205
VWAP
0,199
Alin
0,195
VaihtoMäärä
1 4 931 647
VWAP
0,199
Ylin
0,205
Alin
0,195
VaihtoMäärä
1 4 931 647

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Ostaneet eniten

Ostaneet eniten
VälittäjäOstettuMyytyNettoSisäinen
Anonyymi5 085 6535 085 65300

Myyneet eniten

Myyneet eniten
VälittäjäOstettuMyytyNettoSisäinen
Anonyymi5 085 6535 085 65300

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2025 Q4 -tulosraportti
24.2.
Menneet tapahtumat
2025 Q3 -tulosraportti26.11.2025
2025 Q2 -tulosraportti28.8.2025
2025 Q1 -tulosraportti14.5.2025
2024 Q4 -tulosraportti25.2.2025
2024 Q3 -tulosraportti27.11.2024

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 Q3 -tulosraportti
51 päivää sitten42 min

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2025 Q4 -tulosraportti
24.2.
Menneet tapahtumat
2025 Q3 -tulosraportti26.11.2025
2025 Q2 -tulosraportti28.8.2025
2025 Q1 -tulosraportti14.5.2025
2024 Q4 -tulosraportti25.2.2025
2024 Q3 -tulosraportti27.11.2024

Tuotteita joiden kohde-etuutena tämä arvopaperi

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 5 t sitten · Muokattu
    ·
    5 t sitten · Muokattu
    ·
    https://forum.placera.se/inlagg/4aecd25e-329a-4f7e-bd0c-92af5adb6ea4 What is being discussed on the Placera forum now is old November 2025 news. But Carlsquare projects a 649 % increase in "net sales" (2026E). Is that realistic or a pipe dream? Carlsquare's bear-case is 26 øre; yes, we are currently below that. Bull-case 1.8 kroner, but this must be adjusted for 100x now in February, so the new Nov-2025 corrected bear-case becomes kr 26 and kr 180 (lala-land?) https://carlsquare.com/wp-content/uploads/2025/11/Research-update-Immunovia-q3-2025-final.pdf
    4 t sitten
    ·
    4 t sitten
    ·
    Very difficult to interpret their analysis and sales estimates. They probably expect about 100 tests sold in 2025, and 800 2025, based on scaling up out-of-pocket sales. Whether that is reasonable or not, I have no idea.
  • 1 päivä sitten · Muokattu
    ·
    1 päivä sitten · Muokattu
    ·
    15:13:57 is probably a unique daily event. This is probably one of the larger stock trades in a long time, today 15. January.
    8 t sitten
    ·
    8 t sitten
    ·
    What happened then?
    5 t sitten · Muokattu
    ·
    5 t sitten · Muokattu
    ·
    Approximately 2 million shares changed hands in a single trade. I thought it was such an abnormal pattern that I wanted to mention it. Because we have had weeks of little interest in the stock. It has gone sideways, but you have also observed that the stock has minimal trust. Without trust, people do not dare to make trades. So, there has probably been a combination of investors and small-scale investors who have already left the stock. They are on greener pastures for now, I would assume? You will probably have some who believe in a correction, who do not want to take any loss. They are stuck with perhaps 10 to 70 øre negative price per their shares (figures taken a bit out of thin air, but I assume this since, approximately if one has been holding since August 2025). Because then the price was close to 1 krone. We all have different GAV, but there is probably an average. Where most people are with their investment. To make it bubble a bit, one must approach something towards GAV where people regain room to maneuver. In my eyes, the stock price is so low that people rather choose to wait. You will have some who throw in the towel then. But you will still have those who still have room to maneuver, either because they have larger holdings and / or larger cash reserves. Plus this eternal short-seller thing. They profit from decline. But they also do not profit from stagnation. There is a majority of negative sentiment, which means that as soon as someone starts buying, you have those who want out, you have short sellers, you have those with more room to maneuver. There are very many factors against turning such a stagnant stock price around. Then small news sprinkles do little good. This is "my 50 øre" (how I perceive things).
  • 1 päivä sitten · Muokattu
    ·
    1 päivä sitten · Muokattu
    ·
    For another stock, or even Immunovia on better price trends, a small insignificant piece of news showing that something is happening would have made the stock price jump up. But not for Immunovia in its current standing. Even several of the news items we saw in autumn 2025 would probably have been price-driving upwards normally. Just trying to say something about how bad the confidence in the stock is. Have a nice day. Here is today's news, apparently. I found it on the Placera forum https://www.linkedin.com/posts/immunovia-ab_earlydetection-cancerawareness-biomarkers-activity-7417331828698816512-CJlp?utm_source=share&utm_medium=member_ios&rcm=ACoAAACpSGUBjjAlR2zB3dOwz9LsNy5ipwhw7A0
  • 2 päivää sitten · Muokattu
    ·
    2 päivää sitten · Muokattu
    ·
    @Micketro Hi, I see that you are replying in the Placera forum as Krosen. https://forum.placera.se/inlagg/32d5c8b1-4053-4ed5-9a85-46bc1c7ef9a9 There's nothing new under the sun, I guess. If you yourself are an owner in the stock, what's the point of strengthening pessimism? There are probably others who write pessimistically. I'm just a little disappointed that the serious ones are starting to become slightly pessimistic, if you understand. One only helps short sellers feel more secure. Just saw around 10 o'clock someone on the sell side with over a million shares for sale. https://www.fi.se/sv/vara-register/blankningsregistret/emittent?id=549300KHWL6KK1XGUO81
    2 päivää sitten · Muokattu
    ·
    2 päivää sitten · Muokattu
    ·
    As soon as someone with larger stock positions sells out, it will automatically lead to a large drop. Why people don't have the nerve and at least wait until Q2 in 2026, the financial report, which the company has enough financing to reach. That's certainly their business.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    2 million shares at this level is almost nothing in terms of money for the richer ones, even if such sums mean a bit to me. Then they are far from empty, and there is probably one or another guarantor who believes in Immunovia too, right?
  • 9.1.
    ·
    9.1.
    ·
    Following Immunovia on Linkedin and it's clear that they are really investing commercially now. They have recruited 3 Account Managers and some other commercial roles. Naturally, this also means increased costs so... hopefully, sales will slowly start to pick up.
    22 t sitten
    ·
    22 t sitten
    ·
    7 421 900 %. the stock must go up if I am to break even. I'm holding on and strongly believe in the company👍
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

SwedenNasdaq Stockholm
Määrä
Osto
6 100
Myynti
Määrä
19 880

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
1--
3 035--
5 841--
2 000--
119--
Ylin
0,205
VWAP
0,199
Alin
0,195
VaihtoMäärä
1 4 931 647
VWAP
0,199
Ylin
0,205
Alin
0,195
VaihtoMäärä
1 4 931 647

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Ostaneet eniten

Ostaneet eniten
VälittäjäOstettuMyytyNettoSisäinen
Anonyymi5 085 6535 085 65300

Myyneet eniten

Myyneet eniten
VälittäjäOstettuMyytyNettoSisäinen
Anonyymi5 085 6535 085 65300